In conclusion , this review highlights the benefits of bariatric surgery in reducing or eliminating risk factors for CVD .
It provides further evidence to support surgical treatment of obesity to achieve CVD risk reduction
Obesity is associated with increased risk for cardiovascular ( CV ) disease ( CVD ) and CV mortality .
Bariatric surgery has been shown to resolve or improve CVD risk factors , to varying degrees .
The objective of this systematic review was to determine the impact of bariatric surgery on CV risk factors and mortality .
A systematic review of the published research was performed to evaluate evidence regarding CV outcomes in morbidly obese bariatric patients .
Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band.
BACKGROUND Obesity and its related comorbid illnesses have become a national health priority . We report comorbidity and quality of life ( QoL ) data after  weight loss with gastric b and ing  using the Swedish Adjustable Gastric B and ( SAGB ) . METHODS Data were collected prospect ively for 838 consecutive morbidly obese patients who underwent laparoscopic adjustable gastric b and ing ( LAGB ) between January 2001 and July 2007 . Patients were followed-up by a multidisciplinary team consisting of a surgeon , physician , dietician , and exercise consultant , all of whom were involved in the evaluation of clinical outcomes . Continuous data were reported as mean + /- SD ; categorical data were reported as number and percentage . Patients served as their own controls . RESULTS Respective preoperative mean age , weight , and body mass index ( BMI ) were 44 years ( range 16 - 76 ) , 122 kg ( range 86 - 240 ) , and 44 kg/m2 ( range 35 - 86 ) , respectively . SAGB implantation was accomplished by the pars flaccida technique with no conversion to an open procedure . Mature follow-up data were available for 35 % of patients at 24 months and 21 % at 36 months . In the total cohort of 838 patients , BMI ( mean + /- SD ) decreased to 32 + /- 5 kg/m2 and 32 + /- 7 kg/m2 at 24 months and 36 months , respectively . Percentage excess weight loss ( % EWL ) ( mean + /- SD ) was 32 % + /- 14 % ( n = 506 ) , 47 % + /- 15 % ( n = 461 ) , 52 % + /- 16 % ( n = 291 ) , and 54 % + /- 23 % ( n = 175 ) at 6 , 12 , 24 , and 36 months , respectively ( P < .001 ) . There were 545 patients identified with comorbid illness at > 6-month follow-up . After a median follow-up of 13 months ( range 6 - 36 months ) , resolution and /or improvement of comorbidities was as follows : type 2 diabetes mellitus , 79 % ; metabolic syndrome , 78 % ; hypertension , 67 % ; dyslipidemia , 66 % ; gastroesophageal reflux , 66 % ; asthma , 57 % ; arthritis/joint pain , 70 % ; polycystic ovarian syndrome , 48 % ; and depression , 57 % . There was a significant improvement in QoL ( as measured by the Short Form-36 Health Survey [ SF-36 ] ) , bringing patients ' QoL to a level consistent with that of community norms in all 8 domain scores . Of 342 patients surveyed with the Beck Depression Inventory ( BDI-II ) , a statistically significant improvement in depressive mood was also observed ( P < .001 ) . CONCLUSION Weight loss achieved by use of the SAGB provides a dramatic reduction in many serious comorbid illnesses as well as improvement in the psychosocial wellbeing of morbidly obese patients
In conclusion , this review highlights the benefits of bariatric surgery in reducing or eliminating risk factors for CVD .
It provides further evidence to support surgical treatment of obesity to achieve CVD risk reduction
Obesity is associated with increased risk for cardiovascular ( CV ) disease ( CVD ) and CV mortality .
Bariatric surgery has been shown to resolve or improve CVD risk factors , to varying degrees .
The objective of this systematic review was to determine the impact of bariatric surgery on CV risk factors and mortality .
A systematic review of the published research was performed to evaluate evidence regarding CV outcomes in morbidly obese bariatric patients .